An imported case of severe falciparum malaria with prolonged hemolytic anemia clinically mimicking a coinfection with babesiosis
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
While imported falciparum malaria has been increasingly reported in recent years in Korea, clinicians have difficulties in making a clinical diagnosis as well as in having accessibility to effective anti-malarial agents. Here we describe an unusual case of imported falciparum malaria with severe hemolytic anemia lasting over 2 weeks, clinically mimicking a coinfection with babesiosis. A 48-year old Korean man was diagnosed with severe falciparum malaria in France after traveling to the Republic of Benin, West Africa. He received a 1-day course of intravenous artesunate and a 7-day course of Malarone (atovaquone/proguanil) with supportive hemodialysis. Coming back to Korea 5 days after discharge, he was readmitted due to recurrent fever, and further treated with Malarone for 3 days. Both the peripheral blood smears and PCR test were positive for Plasmodium falciparum. However, he had prolonged severe hemolytic anemia (Hb 5.6 g/dl). Therefore, 10 days after the hospitalization, Babesia was considered to be potentially coinfected. A 7-day course of Malarone and azithromycin was empirically started. He became afebrile within 3 days of this babesiosis treatment, and hemolytic anemia profiles began to improve at the completion of the treatment. He has remained stable since his discharge. Unexpectedly, the PCR assays failed to detect DNA of Babesia spp. from blood. In addition, during the retrospective review of the case, the artesunate-induced delayed hemolytic anemia was considered as an alternative cause of the unexplained hemolytic anemia.
Abstract
While imported falciparum malaria has been increasingly reported in recent years in Korea, clinicians have difficulties in making a clinical diagnosis as well as in having accessibility to effective anti-malarial agents. Here we describe an unusual case of imported falciparum malaria with severe hemolytic anemia lasting over 2 weeks, clinically mimicking a coinfection with babesiosis. A 48-year old Korean man was diagnosed with severe falciparum malaria in France after traveling to the Republic of Benin, West Africa. He received a 1-day course of intravenous artesunate and a 7-day course of Malarone (atovaquone/proguanil) with supportive hemodialysis. Coming back to Korea 5 days after discharge, he was readmitted due to recurrent fever, and further treated with Malarone for 3 days. Both the peripheral blood smears and PCR test were positive for Plasmodium falciparum. However, he had prolonged severe hemolytic anemia (Hb 5.6 g/dl). Therefore, 10 days after the hospitalization, Babesia was considered to be potentially coinfected. A 7-day course of Malarone and azithromycin was empirically started. He became afebrile within 3 days of this babesiosis treatment, and hemolytic anemia profiles began to improve at the completion of the treatment. He has remained stable since his discharge. Unexpectedly, the PCR assays failed to detect DNA of Babesia spp. from blood. In addition, during the retrospective review of the case, the artesunate-induced delayed hemolytic anemia was considered as an alternative cause of the unexplained hemolytic anemia.
참고문헌 (20)
- "Epidemiologic characteristics of imported malaria in Korea, 2003-2012"[URL]
- Hae Suk Cheong, "Imported Malaria in Korea: a 13-Year Experience in a Single Center", The Korean Journal of Parasitology, 47(3), pp.299~302 (2009), 대한기생충학ㆍ열대의학회
- 안명희, "해외유입 기생충질환", Infection and Chemotherapy, 42(5), pp.271~279 (2010), 대한감염학회
- 최원섭, "장간막 림프절염으로 발현된 Kikuchi-Fujimoto병 1예", Infection and Chemotherapy, 38(5), pp.300~303 (2006), 대한감염학회
- Veron V, "Multiplex real-time PCR detection of P. falciparum, P. vivax, and P. malariae in human blood samples", Exp Parasitol, 121, pp.346~351 (2009)
- Teal AE, "A new real-time PCR assay for improved detection of the parasite Babesia microti", J Clin Microbiol, 50, pp.903~908 (2012)
- World Health Organization, "Severe falciparum malaria", Trans R Soc Trop Med Hyg, 94(suppl 1), pp.S1~S90 (2000)
- Beda Lüthi, "Risk factors associated with malaria deaths in travellers: A literature review", Travel Medicine and Infectious Disease, 13(1), pp.48~60 (2015), Elsevier BV[DOI]
- Ashley E, "Malaria", Travel Med Infect Dis, 4, pp.159~173 (2006)
- Trampuz A, "Clinical review : Severe malaria", Crit Care, 7, pp.315~323 (2003)
- Jelinek T, "Artemisinin based combination therapy in travel medicine", Travel Med Infect Dis, 11, pp.23~28 (2013)
- Homer MJ, "Babesiosis", Clin Microbiol Rev, 13, pp.451~469 (2000)
- Hunfeld KP, "Babesiosis : recent insights into an ancient disease", Int J Parasitol, 38, pp.1219~1237 (2008)
- Bush JB, "Human babesiosis-a preliminary report of 2 suspected cases in South Africa", S Afr Med J, 78, pp.699~ (1990)
- Casati S, "Presence of potentially pathogenic Babesia sp. for human in Ixodes ricinus in Switzerland", Ann Agric Environ Med, 13, pp.65~70 (2006)
- Thierry Rolling, "Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia", Malaria Journal, 11(1), pp.169~ (2012), Springer Nature[DOI]
- Annemarie R Kreeftmeijer-Vegter, "Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium", Malaria Journal, 11(1), pp.102~ (2012), Springer Nature[DOI]
- Zoller T, "Intravenous artesunate for severe malaria in travelers, Europe", Emerg Infect Dis, 17, pp.771~777 (2011)
- Centers for Disease Control and Prevention (CDC)., "Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria-worldwide, 2010-2012", MMWR Morb Mortal Wkly Rep, 62, pp.5~8 (2013)
- Jauréguiberry S, "Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins", Blood, 124, pp.167~175 (2014)